AU1646983A - Corticoid formulations - Google Patents
Corticoid formulationsInfo
- Publication number
- AU1646983A AU1646983A AU16469/83A AU1646983A AU1646983A AU 1646983 A AU1646983 A AU 1646983A AU 16469/83 A AU16469/83 A AU 16469/83A AU 1646983 A AU1646983 A AU 1646983A AU 1646983 A AU1646983 A AU 1646983A
- Authority
- AU
- Australia
- Prior art keywords
- corticoid
- formulations
- preparations
- cortoicoid
- inflammatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003470 adrenal cortex hormone Substances 0.000 title 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 229940119170 jojoba wax Drugs 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Steroid Compounds (AREA)
Abstract
Topical preparations comprise jojoba oil and 0.005 to 2% by weight of an anti-inflammatory cortoicoid. The preparations are stable even when substantially diluted.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19823225849 DE3225849A1 (en) | 1982-07-07 | 1982-07-07 | PREPARATION OF CORTICOIDS FOR TOPICAL APPLICATION |
| DE3225849 | 1982-07-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU1646983A true AU1646983A (en) | 1984-01-12 |
| AU570638B2 AU570638B2 (en) | 1988-03-24 |
Family
ID=6168122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU16469/83A Ceased AU570638B2 (en) | 1982-07-07 | 1983-07-01 | Corticoid formulations |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0098568B1 (en) |
| JP (1) | JPS5976014A (en) |
| AT (1) | ATE66596T1 (en) |
| AU (1) | AU570638B2 (en) |
| CA (1) | CA1202901A (en) |
| DE (2) | DE3225849A1 (en) |
| DK (1) | DK312483A (en) |
| GB (1) | GB2122899A (en) |
| NZ (1) | NZ204774A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU570639B2 (en) * | 1982-07-07 | 1988-03-24 | Schering Aktiengesellschaft | Corticoid topical formulation |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59137408A (en) * | 1983-01-27 | 1984-08-07 | Taisho Pharmaceut Co Ltd | ointment |
| JPS59139315A (en) * | 1983-01-31 | 1984-08-10 | Taisho Pharmaceut Co Ltd | Cream agent |
| DE3836971C1 (en) * | 1988-10-31 | 1990-05-17 | Weck, Wolfgang, Dr.Med., 6990 Bad Mergentheim, De | |
| RU2180216C2 (en) * | 2000-03-13 | 2002-03-10 | Открытое акционерное общество "Биосинтез" | Preparation eliciting antibacterial and regenerative effect |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI44459B (en) * | 1968-10-25 | 1971-08-02 | K Rehtijaervi | |
| US4070462A (en) * | 1976-10-26 | 1978-01-24 | Schering Corporation | Steroid ointment |
| FR2471775A1 (en) * | 1979-12-18 | 1981-06-26 | Oreal | Cosmetic oils based on jojoba and sunflower oils - contg. added unsaponifiable fraction, used as sun tan preparations, shaving creams etc. |
| FR2474310A1 (en) * | 1980-01-25 | 1981-07-31 | Oreal | STABLE SOLUTION WITH OXIDATION OF VITAMIN F AND JOJOBA OIL AND COSMETIC COMPOSITIONS CONTAINING THE SAME |
| JPS56135416A (en) * | 1980-03-27 | 1981-10-22 | Mitsubishi Chem Ind Ltd | Pharmaceutical preparation for skin |
| SE8004580L (en) * | 1980-06-19 | 1981-12-20 | Draco Ab | PHARMACEUTICAL PREPARATION |
| DE3225848A1 (en) * | 1982-07-07 | 1984-01-19 | Schering AG, 1000 Berlin und 4709 Bergkamen | PREPARATION OF CORTICOIDS FOR TOPICAL APPLICATION |
-
1982
- 1982-07-07 DE DE19823225849 patent/DE3225849A1/en not_active Withdrawn
-
1983
- 1983-07-01 NZ NZ204774A patent/NZ204774A/en unknown
- 1983-07-01 AU AU16469/83A patent/AU570638B2/en not_active Ceased
- 1983-07-04 AT AT83106512T patent/ATE66596T1/en active
- 1983-07-04 EP EP83106512A patent/EP0098568B1/en not_active Expired - Lifetime
- 1983-07-04 DE DE8383106512T patent/DE3382386D1/en not_active Expired - Lifetime
- 1983-07-06 CA CA000431878A patent/CA1202901A/en not_active Expired
- 1983-07-06 JP JP58121699A patent/JPS5976014A/en active Pending
- 1983-07-06 DK DK312483A patent/DK312483A/en not_active Application Discontinuation
- 1983-07-07 GB GB08318397A patent/GB2122899A/en not_active Withdrawn
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU570639B2 (en) * | 1982-07-07 | 1988-03-24 | Schering Aktiengesellschaft | Corticoid topical formulation |
Also Published As
| Publication number | Publication date |
|---|---|
| CA1202901A (en) | 1986-04-08 |
| GB8318397D0 (en) | 1983-08-10 |
| DK312483D0 (en) | 1983-07-06 |
| DE3382386D1 (en) | 1991-10-02 |
| JPS5976014A (en) | 1984-04-28 |
| ATE66596T1 (en) | 1991-09-15 |
| DK312483A (en) | 1984-01-08 |
| GB2122899A (en) | 1984-01-25 |
| EP0098568A2 (en) | 1984-01-18 |
| AU570638B2 (en) | 1988-03-24 |
| NZ204774A (en) | 1986-03-14 |
| EP0098568A3 (en) | 1985-05-15 |
| EP0098568B1 (en) | 1991-08-28 |
| DE3225849A1 (en) | 1984-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU515772B2 (en) | "15-deoxy-16-hydroxyprostaglandins" | |
| AU4284478A (en) | Radiation-curable formulations | |
| ATE62815T1 (en) | ANTI-INFLAMMATORY CREAM. | |
| AU4812179A (en) | Sunblock formulation | |
| AU517598B2 (en) | Derivatives of 1-aza-(2,2,2)-bicyclo-octane | |
| AU4622079A (en) | Substituted 1,3-diaryl-2-imino-imidazolidines and 2-imino- hexahydro-pyrimidines | |
| AU570638B2 (en) | Corticoid formulations | |
| AU521916B2 (en) | Anti-caries preparations | |
| AU535172B2 (en) | 2-cyano-3-azabicyclo(3.1.0) hexane and derivatives | |
| AU530175B2 (en) | Preparation of 2,2:-bis(4-(1,1,3,3-tetramethylbutyl) -phenol)sulphide | |
| SU692622A1 (en) | Ball mill | |
| AU522421B2 (en) | "hydroisoquinolinium derivatives" | |
| AU524991B2 (en) | (thio) hydantion compounds | |
| AU563760B2 (en) | Etofenamate formulations | |
| AU528798B2 (en) | Anti-inflammatory compositions | |
| SU703647A2 (en) | Mud preparation mill | |
| SU706345A1 (en) | Enamel | |
| AU526438B2 (en) | Administration set | |
| AU530721B2 (en) | Cyclododecane derivatives | |
| SU700868A1 (en) | Triangular voltage-to-sinusoidal voltage converter | |
| SU693073A2 (en) | Super-flywheel | |
| SU706346A1 (en) | Enamel | |
| SU672623A1 (en) | Dc voltage stabilizer | |
| AU521027B2 (en) | "2-methoxybenzamides" | |
| AU533384B2 (en) | Corticoid 21 sulphorpropionates |